Literature DB >> 18316120

Poly(beta-amino ester) as a carrier for si/shRNA delivery in lung cancer cells.

Dhananjay Jere1, Cheng-Xiong Xu, Rohidas Arote, Cheol-Heui Yun, Myung-Haing Cho, Chong-Su Cho.   

Abstract

Efficient delivery of small interfering RNA (siRNA) or small hairpin RNA (shRNA) is a critical concern in RNA interference (RNAi) studies. In the present study, we evaluated biodegradable poly(beta-amino ester) (PAE) carrier composed of low molecular weight polyethylenimine and poly(ethylene glycol) for si/shRNA delivery in lung cancer cells. PAE carrier successfully delivered EGFP (enhanced green fluorescence protein) siRNA (siGFP) and silenced EGFP expression. The silencing achieved with PAE carrier was found to be nearly 1.5 times superior and safer than standard PEI25K. Also, our PAE carrier exhibited superior Akt1 shRNA delivery (shAkt) and thereby silenced oncoprotein Akt1 efficiently. PAE-shAkt mediated Akt1 knock-down hindered cancer cell growth in Akt1 specific manner. Superior shAkt delivery and low cytotoxicity of PAE carrier promoted Akt1 knock-down specific apoptosis, while low delivery efficiency and high cytotoxicity of PEI25K carrier mainly exhibited undesirable necrosis. Moreover, basic cancer properties like cell proliferation, malignancy and metastasis were reduced more efficiently using PAE-shAkt system. These findings demonstrated the potential of PAE as an alternative to PEI25K in si/shRNA-based RNAi studies.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18316120     DOI: 10.1016/j.biomaterials.2008.02.018

Source DB:  PubMed          Journal:  Biomaterials        ISSN: 0142-9612            Impact factor:   12.479


  19 in total

1.  Solid lipid nanoparticles loaded with anti-microRNA oligonucleotides (AMOs) for suppression of microRNA-21 functions in human lung cancer cells.

Authors:  San-Jun Shi; Zhi-Rong Zhong; Jie Liu; Zhi-Rong Zhang; Xun Sun; Tao Gong
Journal:  Pharm Res       Date:  2011-07-06       Impact factor: 4.200

2.  Cystamine-terminated poly(beta-amino ester)s for siRNA delivery to human mesenchymal stem cells and enhancement of osteogenic differentiation.

Authors:  Stephany Y Tzeng; Ben P Hung; Warren L Grayson; Jordan J Green
Journal:  Biomaterials       Date:  2012-08-04       Impact factor: 12.479

3.  Rationally Designed Polycationic Carriers for Potent Polymeric siRNA-Mediated Gene Silencing.

Authors:  Connie Wu; Jiahe Li; Wade Wang; Paula T Hammond
Journal:  ACS Nano       Date:  2018-06-28       Impact factor: 15.881

Review 4.  pH-Responsive nanoparticles for drug delivery.

Authors:  Weiwei Gao; Juliana M Chan; Omid C Farokhzad
Journal:  Mol Pharm       Date:  2010-10-27       Impact factor: 4.939

Review 5.  RNA interference for improving the outcome of islet transplantation.

Authors:  Feng Li; Ram I Mahato
Journal:  Adv Drug Deliv Rev       Date:  2010-12-13       Impact factor: 15.470

Review 6.  Nanotoxicity: a key obstacle to clinical translation of siRNA-based nanomedicine.

Authors:  Hui Yi Xue; Shimeng Liu; Ho Lun Wong
Journal:  Nanomedicine (Lond)       Date:  2014-02       Impact factor: 5.307

7.  Gold, poly(beta-amino ester) nanoparticles for small interfering RNA delivery.

Authors:  Jae-Seung Lee; Jordan J Green; Kevin T Love; Joel Sunshine; Robert Langer; Daniel G Anderson
Journal:  Nano Lett       Date:  2009-06       Impact factor: 11.189

8.  Delivery of therapeutic AGT shRNA by PEG-Bu for hypertension therapy.

Authors:  Yu-Qiang Wang; Fei Wang; Xiao-Qin Deng; Jing Sheng; Shu-Yan Chen; Jing Su
Journal:  PLoS One       Date:  2013-07-19       Impact factor: 3.240

Review 9.  Applications of RNA interference in cancer therapeutics as a powerful tool for suppressing gene expression.

Authors:  Song He; Dechun Zhang; Fang Cheng; Fanghong Gong; Yanan Guo
Journal:  Mol Biol Rep       Date:  2009-01-01       Impact factor: 2.316

Review 10.  Nanomedicine in pulmonary delivery.

Authors:  Heidi M Mansour; Yun-Seok Rhee; Xiao Wu
Journal:  Int J Nanomedicine       Date:  2009-12-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.